Aditya Gaur is an Infectious Disease physician affiliated with St. Jude Children's Research Hospital. OpenAlex indexes 187 publications with 7,663 citations (h-index 43); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Triggered Escalating Real-time Adherence (TERA) Intervention
Sponsor: University of North Carolina, Chapel Hill
- First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor
Sponsor: St. Jude Children's Research Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
1 NIH research award on record, funded 2011–2015 per NIH RePORTER. The latest:
- St. Jude-Memphis Adolescent Trials Unit
St. Jude Children'S Research Hospital
FY2015$817,570U01HD052239 - St. Jude-Memphis Adolescent Trials Unit
St. Jude Children'S Research Hospital
FY2014$703,910U01HD052239 - St. Jude-Memphis Adolescent Trials Unit
St. Jude Children'S Research Hospital
FY2013$669,382U01HD052239
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
New England Journal of Medicine
2024 - Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
New England Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Merchant, DO
St. Jude Children's Research Hospital
Karen Slobod, MD
St. Jude Children's Research Hospital
Jeffrey Towbin, MD
St. Jude Children's Research Hospital
Raul Ribeiro, MD
St. Jude Children's Research Hospital
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”